AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Desvenlafaxine Succinate in South Africa
2 products registered with SAHPRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EXSIRA 100 mg | 41/1.2/0427 | Pfizer Laboratories (Pty) Ltd | active | 1 Jan 1900 |
| EXSIRA 50 mg | 42/1.2/0935 | Pfizer Laboratories (Pty) Ltd | active | 1 Jan 1900 |
Desvenlafaxine Succinate — SAHPRA Registration Details
SAHPRA (South Africa) has 2 registered products containing Desvenlafaxine Succinate, of which 2 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Desvenlafaxine Succinate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.